This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.



We don’t just want to control malaria; we want to eliminate it everywhere. We’re creating vaccines, finding treatments, inventing faster diagnostic tools, piloting new approaches, and putting data to work in completely new ways to prevent and stop outbreaks.

Our Work
Articles from our global team
79 Articles
79 Articles
79 Articles
  1. Pyrethroid Resistance in Malaria Vectors
    February 28, 2020

    Harnessing the power of routine data to eliminate malaria

    New evidence indicates that analyzing routine data can be a low-cost way to determine the impact of new tools for reducing the malaria burden.

  2. Mulenga Mwenda-Chimfwembe genotypes malaria parasites and searches for molecular markers of drug resistance at Zambia's National Malaria Eradication Center.he National Malaria Eradication Center in Zambia.
    February 27, 2020

    Mulenga Mwenda-Chimfwembe’s battle against malaria

    Malaria nearly killed Mulenga Mwenda-Chimfwembe several times throughout her childhood. Now, she devotes her career as a scientist at PATH to fighting it.

  3. 07850_hr.jpg
  4. Kammerle Schneider
    October 21, 2019

    Kammerle Schneider appointed director, Malaria and Neglected Tropical Disease programs

  5. A team of scientists and researchers at PATH focuses on advancing high-impact diagnostic technologies. Photo: PATH/Patrick McKern.
    October 18, 2019

    4 ways diagnostic innovations improve outcomes and accelerate health equity

    From eliminating diseases to detecting and curbing outbreaks, diagnostics play many essential roles in global health. Here we explore four key ways that PATH, our partners, and our diagnostic innovations are strengthening the health of individuals and communities around the world.

  6. SD BIOSENSOR’s STANDARD G6PD Test is a handheld device that delivers results in two minutes and provides a quantitative measure of G6PD enzyme  activity, including in heterozygous women.
    October 3, 2019

    Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives

    The STANDARD™ G6PD has achieved provisional Expert Review Panel for Diagnostics (ERPD) approval, which enables procurement with Global Fund and Unitaid funds. Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of Plasmodium vivax malaria and efforts to eliminate the disease.

Load more